Journey Medical Corporation (DERM) Reports Q2 Loss, Tops Revenue Estimates
DERMJourney Medical (DERM) ZACKS·2024-08-13 06:10

Journey Medical Corporation (DERM) came out with a quarterly loss of 0.17pershareversustheZacksConsensusEstimateofalossof0.17 per share versus the Zacks Consensus Estimate of a loss of 0.15. This compares to loss of 0.46pershareayearago.Thesefiguresareadjustedfornon−recurringitems.Thisquarterlyreportrepresentsanearningssurpriseof−13.330.46 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -13.33%. A quarter ago, it was expected that this company would post a loss of 0.26 per share when it actually produced a loss of $0.53, delivering a surprise of -103.85%.Over the last four quarters, the compa ...